Experience a leap forward in T-cell analysis with 100XBIO. Our robotic platform multiplies your data, accelerating your research and bringing new immune therapies to life faster.
For demonstration purposes only; actual product may vary.
Led by founder Sergei Pustylnikov, PhD, we are committed to transforming R&D of T cell-mediated
therapies, empowering researchers to accelerate advancements in precision medicine.
100XBIO @C2I Accelerator
299 Washington St
Woburn, MA 01801
contact@100xbio.com
.png){kind=small}
